Abstract
This paper reports the synthesis, characterization, and cellular uptake of the conjugate of porphyrin and iron oxide nanoparticles, which may lead to a bimodal anticancer agent that can be used in the combinational treatment of photodynamic therapy (PDT) and hyperthermia therapy (HT).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / pharmacokinetics*
-
Ferric Compounds / chemistry*
-
HeLa Cells
-
Humans
-
Hyperthermia, Induced
-
Microscopy, Electron, Transmission
-
Nanoparticles*
-
Particle Size
-
Photochemotherapy
-
Porphyrins / chemical synthesis*
-
Porphyrins / pharmacokinetics*
-
Spectrometry, Fluorescence
-
Spectrophotometry, Ultraviolet
Substances
-
Antineoplastic Agents
-
Ferric Compounds
-
Porphyrins
-
ferric oxide